SAM
Sagewood Asset Management Portfolio holdings
AUM
$282M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$282M
AUM Growth
–
Holding
264
Top Buys
| 1 | +$29.6M | |
| 2 | +$14.2M | |
| 3 | +$12.9M | |
| 4 |
Apple
AAPL
|
+$11.5M |
| 5 |
NVIDIA
NVDA
|
+$11.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 31.59% |
| 2 | Technology | 23.12% |
| 3 | Consumer Staples | 8.53% |
| 4 | Communication Services | 7.16% |
| 5 | Healthcare | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Kosmos Energy
KOS
$1,000M
| $41.6K | 0.01% |
+45,890
|
|
||
252
Microvision
MVIS
$257M
| $27.8K | 0.01% |
+33,597
|
|
||
253
Geron
GERN
$1.1B
| $25.1K | 0.01% |
+19,017
|
|
||
254
Allogene Therapeutics
ALLO
$569M
| $22.8K | 0.01% |
+16,625
|
|
||
|
TEAD
255
Teads Holding Co
TEAD
$76M
| $21.9K | 0.01% |
+31,131
|
|
||
256
MaxCyte
MXCT
$84.9M
| $21.1K | 0.01% |
+13,598
|
|
||
257
Coherus Oncology
CHRS
$251M
| $20.9K | 0.01% |
+14,732
|
|
||
258
Accuray
ARAY
$71.3M
| $18.8K | 0.01% |
+22,793
|
|
||
259
PLAYSTUDIOS Inc
MYPS
$64.7M
| $16.7K | 0.01% |
+25,629
|
|
||
260
Agilon Health
AGL
$207M
| $15.8K | 0.01% |
+22,949
|
|
||
261
Fate Therapeutics
FATE
$171M
| $14.7K | 0.01% |
+15,003
|
|
||
262
Standard BioTools
LAB
$450M
| $13.1K | ﹤0.01% |
+10,271
|
|
||
263
Advantage Solutions
ADV
$181M
| $12.7K | ﹤0.01% |
+14,408
|
|
||
264
BRC Inc
BRCC
$74.5M
| $12K | ﹤0.01% |
+10,787
|
|